Sufficient numbers of anti-tumor T cells is a condition of maximal efficacy of anti-hypoxia-A2-adenosinergic drugs during cancer immunotherapy
Year: 2020
Type: article
Source: Current Opinion in Pharmacology
Author: Michail V Sitkovsky
Institution: Northeastern University
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3081906836
